AI assistant
ORTHOPEDIATRICS CORP — Director's Dealing 2017
Oct 11, 2017
32906_dirs_2017-10-11_9e85ca0a-5b6b-4461-a6a9-47ecbb3dc828.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ORTHOPEDIATRICS CORP (KIDS)
CIK: 0001425450
Period of Report: 2017-10-11
Reporting Person: Squadron Capital LLC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1206 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $30.97 | 2022-08-23 | Common Stock (1340) | Direct | |
| Series A Convertible Preferred Stock | $23.88 | Common Stock (670000) | Direct | ||
| Series B Convertible Preferred Stock | $13.09 | Common Stock (2785833) | Direct |
Footnotes
F1: The stock option is fully vested and immediately exercisable.
F2: All outstanding shares of Series A Convertible Preferred Stock (the "Series A Stock") are held by the reporting person. The Series A Stock is convertible at any time at the reporting person's election into shares of Common Stock at the then-existing conversion price, and has no expiration date. Upon the closing of the initial public offering of the Common Stock, a $16.0 million preference payment, together with all accrued and unpaid dividends, on the Series A Stock will automatically convert into shares of Common Stock at a conversion price equal to the initial public offering price.
F3: The Series B Convertible Preferred Stock is convertible at any time at the holder's election into shares of Common Stock at the then-existing conversion price, and has no expiration date.